XELPROS XPRESS

Serial Number 88229056
Registration 5970441
700

Registration Progress

Application Filed
Dec 13, 2018
Under Examination
Approved for Publication
Nov 12, 2019
Published for Opposition
Nov 12, 2019
Registered
Jan 28, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-01-28)
Due: Jan 28, 2026 198 days

Trademark Image

XELPROS XPRESS

Basic Information

Serial Number
88229056
Registration Number
5970441
Filing Date
December 13, 2018
Registration Date
January 28, 2020
Published for Opposition
November 12, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 28, 2020
Registration
Registered
Classes
035 039

Rights Holder

Sun Pharma Advanced Research Company Limited

16
Address
17-B, Mahal Industrial Estate,
Mahakali Caves Road, Andheri (East)
Mumbai 400063
IN

Ownership History

Sun Pharma Advanced Research Company Limited

Original Applicant
16
Mumbai IN

Sun Pharma Advanced Research Company Limited

Owner at Publication
16
Mumbai IN

Sun Pharma Advanced Research Company Limited

Original Registrant
16
Mumbai IN

Legal Representation

Attorney
Craig Kuchii, Esq.

USPTO Deadlines

Next Deadline
198 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-01-28)
Due Date
January 28, 2026
Grace Period Ends
July 28, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description
Jan 28, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 28, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 12, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2019 PUBO A PUBLISHED FOR OPPOSITION
Oct 23, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 10, 2019 ALIE A ASSIGNED TO LIE
Oct 7, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 5, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2019 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 4, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2019 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 26, 2019 GNFR O FINAL REFUSAL E-MAILED
Jul 26, 2019 CNFR R FINAL REFUSAL WRITTEN
Jun 21, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2019 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Mar 23, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 23, 2019 GNRT F NON-FINAL ACTION E-MAILED
Mar 23, 2019 CNRT R NON-FINAL ACTION WRITTEN
Mar 23, 2019 IUAA P USE AMENDMENT ACCEPTED
Mar 21, 2019 AUPC I AMENDMENT TO USE PROCESSING COMPLETE
Mar 21, 2019 IUAF S USE AMENDMENT FILED
Mar 20, 2019 EAAU I TEAS AMENDMENT OF USE RECEIVED
Mar 11, 2019 DOCK D ASSIGNED TO EXAMINER
Jan 6, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 035
Retail pharmacy services; mail order pharmacy services; pharmaceutical services, namely, processing telephone prescription orders in retail and central fill pharmacies
First Use Anywhere: Jan 2, 2019
First Use in Commerce: Jan 2, 2019
Class 039
Distribution services, namely, delivery of pharmaceutical products
First Use Anywhere: Jan 2, 2019
First Use in Commerce: Jan 2, 2019

Additional Information

Pseudo Mark
XEL PROS EXPRESS

Classification

International Classes
035 039

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"EXPRESS"

USPTO Documents

Loading USPTO documents...